WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$10.8B
(+18%)
Cap. Flow
+$854M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
169
Reduced
127
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dynatrace
DT
$15.3B
| $19.2M | 0.18% | 413,631 +163,230 | +65% | +$7.58M |
|
177
Waste Connections
WCN
$47.5B
| $19.2M | 0.18% | 111,385 +45,718 | +70% | +$7.86M |
|
178
Scholar Rock
SRRK
$3.14B
| $18.9M | 0.17% | 1,061,750 +136,867 | +15% | +$2.43M |
|
179
IDEAYA Biosciences
IDYA
$2.15B
| $18.7M | 0.17% | 426,002 +11,943 | +3% | +$524K |
|
180
Ultragenyx Pharmaceutical
RARE
$2.89B
| $18.7M | 0.17% | 400,124 | – | – |
|
181
Brinker International
EAT
$6.94B
| $18.7M | 0.17% | 375,665 +213,541 | +132% | +$10.6M |
|
182
Protagonist Therapeutics
PTGX
$3.67B
| $18.4M | 0.17% | +636,956 | New | +$18.4M |
|
183
International Paper
IP
$26.2B
| $18.4M | 0.17% | 471,794 +148,956 | +46% | +$5.81M |
|
184
Jabil
JBL
$22B
| $18.1M | 0.17% | +135,372 | New | +$18.1M |
|
185
XPO
XPO
$15.3B
| $18.1M | 0.17% | +148,177 | New | +$18.1M |
|
186
Immunocore
IMCR
$1.62B
| $17.8M | 0.16% | 274,038 +173,710 | +173% | +$11.3M |
|
|
SWAV
187
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $17.8M | 0.16% | +54,545 | New | +$17.8M |
|
188
Quest Diagnostics
DGX
$20.3B
| $17.6M | 0.16% | +132,231 | New | +$17.6M |
|
189
Adobe
ADBE
$151B
| $17.6M | 0.16% | 34,874 +10,785 | +45% | +$5.44M |
|
190
Arvinas
ARVN
$568M
| $17.4M | 0.16% | 422,204 +34,574 | +9% | +$1.43M |
|
191
Biogen
BIIB
$19.4B
| $17.4M | 0.16% | 80,600 | – | – |
|
192
Xylem
XYL
$34.5B
| $17.3M | 0.16% | 133,901 -274,247 | -67% | -$35.4M |
|
193
Neurocrine Biosciences
NBIX
$13.8B
| $17M | 0.16% | 123,242 +21,960 | +22% | +$3.03M |
|
194
Dynavax Technologies
DVAX
$1.19B
| $17M | 0.16% | 1,368,767 +79,075 | +6% | +$981K |
|
195
Walt Disney
DIS
$213B
| $16.7M | 0.15% | 136,821 -127,670 | -48% | -$15.6M |
|
196
Crescent Energy
CRGY
$2.43B
| $16.3M | 0.15% | +1,368,658 | New | +$16.3M |
|
197
Arrowhead Research
ARWR
$3.05B
| $15.9M | 0.15% | 555,628 -371,559 | -40% | -$10.6M |
|
198
NVR
NVR
$22.4B
| $15.8M | 0.15% | 1,949 -1,222 | -39% | -$9.9M |
|
199
McKesson
MCK
$85.4B
| $15.4M | 0.14% | +28,727 | New | +$15.4M |
|
|
EXE
200
Expand Energy Corporation Common Stock
EXE
$23B
| $15.4M | 0.14% | +173,400 | New | +$15.4M |
|